Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS? [Yahoo! Finance]
Omnicell, Inc. (OMCL)
Last omnicell, inc. earnings: 2/6 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.omnicell.com
Company Research
Source: Yahoo! Finance
Haemonetics intends to use the proceeds from this transaction for general corporate purposes and additional investments in growth initiatives. The transaction comprises a total cash consideration of up to $67.1 million, which includes $44.6 million in upfront and up to $22.5 million in contingent earn-outs over the next four years. Subsequent to the news, the share price of HAE remained unchanged at $85.26 in Tuesday's after-market trading. Haemonetics is continuously focusing on portfolio evolution to enhance leadership in commercial and non-commercial plasma and expand its presence in high-growth hospital markets through various sell-offs. The latest transaction is followed by Haemonetics' agreement in 2020 to sell its Fajardo, Puerto Rico manufacturing operations to GVS and enter a long-term supply and development agreement granting GVS exclusive rights to manufacture and supply the proprietary blood filters produced at the Fajardo facility for Haemonetics. The latest agreeme
Show less
Read more
Impact Snapshot
Event Time:
OMCL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OMCL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OMCL alerts
High impacting Omnicell, Inc. news events
Weekly update
A roundup of the hottest topics
OMCL
News
- Why Omnicell (OMCL) Might be Well Poised for a Surge [Yahoo! Finance]Yahoo! Finance
- New Strong Buy Stocks for December 18th [Yahoo! Finance]Yahoo! Finance
- Omnicell, Inc. (NASDAQ: OMCL) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Multi-Million Drug Therapy Innovations Bring Challenges to Healthcare [Yahoo! Finance]Yahoo! Finance
- Omnicell Announces OmniSphere [Yahoo! Finance]Yahoo! Finance
OMCL
Earnings
- 10/30/24 - Beat
OMCL
Sec Filings
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- 12/12/24 - Form 4
- OMCL's page on the SEC website